As of January 22, 2025, PepGen (PEPG) has a market cap of $64.539 million USD. According to our data, PepGen is ranked No.8009 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $64.54 M |
-47.76%
|
Dec 31, 2024 | $0.12 B |
-44.26%
|
Dec 29, 2023 | $0.22 B |
-49.14%
|
Dec 30, 2022 | $0.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Market Cap | = | PEPG Stock Price | * | PEPG Shares Outstanding |
= | $1.98 | * | 32.60 M | |
= | $64.54 M |